🇺🇸 vasodilator-based PAH therapy in United States

vasodilator-based PAH therapy (vasodilator-based PAH therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

vasodilator-based PAH therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is vasodilator-based PAH therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for vasodilator-based PAH therapy in United States?

Kazuya Hosokawa is the originator. The local marketing authorisation holder may differ — check the official source linked above.